Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma, a Single-Institution Experience.
Sawalha Y, Hill BT, Rybicki LA, Sun D, Dean RM, Jagadeesh D, Hamilton BK, Gerds AT, Sobecks RM, Andresen S, Liu HK, Majhail NS, Pohlman B, Kalaycio ME, Bolwell BJ, Smith MR. Sawalha Y, et al. Among authors: andresen s. Clin Lymphoma Myeloma Leuk. 2018 Jan;18(1):e95-e102. doi: 10.1016/j.clml.2017.11.002. Epub 2017 Dec 6. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29208403
Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancer.
Hamilton BK, Rybicki L, Abounader D, Andresen S, Kalaycio M, Sobecks R, Pohlman B, Hanna R, Dean R, Liu H, Hill B, Bolwell B, Copelan E. Hamilton BK, et al. Among authors: andresen s. Hematol Oncol Stem Cell Ther. 2015 Sep;8(3):115-24. doi: 10.1016/j.hemonc.2015.06.005. Epub 2015 Jul 7. Hematol Oncol Stem Cell Ther. 2015. PMID: 26183670 Free article.
Daily Weight-Based Busulfan with Cyclophosphamide and Etoposide Produces Comparable Outcomes to Four-Times-Daily Busulfan Dosing for Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
Hill BT, Rybicki L, Carlstrom KD, Jagadeesh D, Gerds A, Hamilton B, Liu H, Dean R, Sobecks R, Pohlman B, Andresen S, Kalaycio M, Bolwell BJ, Majhail NS. Hill BT, et al. Among authors: andresen s. Biol Blood Marrow Transplant. 2016 Sep;22(9):1588-1595. doi: 10.1016/j.bbmt.2016.06.011. Epub 2016 Jun 22. Biol Blood Marrow Transplant. 2016. PMID: 27343718 Free article.
Intravenous compared to oral busulfan with cyclophosphamide for autologous hematopoietic cell transplant conditioning for plasma cell myeloma.
Mustafa Ali M, Corrigan DM, Rybicki LA, Yurch MA, Cherni K, Liu H, Dean R, Hamilton B, Pohlman B, Andresen S, Kalaycio M, Bolwell BJ, Majhail NS, Sobecks R. Mustafa Ali M, et al. Among authors: andresen s. Hematol Oncol Stem Cell Ther. 2018 Dec;11(4):253-256. doi: 10.1016/j.hemonc.2018.03.006. Epub 2018 Apr 24. Hematol Oncol Stem Cell Ther. 2018. PMID: 29705567 Free article. No abstract available.
Superior survival after replacing oral with intravenous busulfan in autologous stem cell transplantation for non-Hodgkin lymphoma with busulfan, cyclophosphamide and etoposide.
Dean RM, Pohlman B, Sweetenham JW, Sobecks RM, Kalaycio ME, Smith SD, Copelan EA, Andresen S, Rybicki LA, Curtis J, Bolwell BJ. Dean RM, et al. Among authors: andresen s. Br J Haematol. 2010 Jan;148(2):226-34. doi: 10.1111/j.1365-2141.2009.07940.x. Epub 2009 Oct 11. Br J Haematol. 2010. PMID: 19821828 Free article.
Nonmyeloablative second transplants are associated with lower nonrelapse mortality and superior survival than myeloablative second transplants.
Hill BT, Bolwell BJ, Rybicki L, Dean R, Kalaycio M, Pohlman B, Tench S, Sobecks R, Andresen S, Copelan E. Hill BT, et al. Among authors: andresen s. Biol Blood Marrow Transplant. 2010 Dec;16(12):1738-46. doi: 10.1016/j.bbmt.2010.06.009. Epub 2010 Jun 14. Biol Blood Marrow Transplant. 2010. PMID: 20558313 Free article.
The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls.
Hill BT, Rybicki L, Bolwell BJ, Smith S, Dean R, Kalaycio M, Pohlman B, Tench S, Sobecks R, Andresen S, Copelan E, Sweetenham J. Hill BT, et al. Among authors: andresen s. Br J Haematol. 2011 Mar;152(5):561-9. doi: 10.1111/j.1365-2141.2010.08549.x. Epub 2011 Jan 12. Br J Haematol. 2011. PMID: 21223255 Free article.
Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma.
Hill BT, Rybicki L, Smith S, Dean R, Kalaycio M, Pohlman B, Sweetenham J, Tench S, Sobecks R, Andresen S, Copelan E, Bolwell BJ. Hill BT, et al. Among authors: andresen s. Leuk Lymphoma. 2011 Jun;52(6):986-93. doi: 10.3109/10428194.2010.551154. Epub 2011 Feb 14. Leuk Lymphoma. 2011. PMID: 21314484
160 results